» Articles » PMID: 34307224

Childhood Pemphigus Vulgaris is a Challenging Diagnosis

Abstract

Pemphigus Vulgaris (PV) is an uncommon autoimmune and blistering mucocutaneous disease. Childhood Pemphigus Vulgaris (CPV) is a pediatric variant of PV, which affects children below 12 years, being very rare among children under 10 years of age. CPV has similar clinical, histological, and immunological features as seen in PV in adults. The mucocutaneous clinical presentation is the most common in both age groups. Vesicles and erosions arising from the disease usually cause pain. A few CPV cases have been reported in the literature. This study reports a case of an 8-year-old male patient with oral lesions since the age of 3 years, and the diagnosis of pemphigus was achieved only 2 years after the appearance of the initial lesions. CPV remains a rare disease, making the diagnosis of this clinical case a challenge due to its age of onset and clinical features presented by the patient. Therefore, dentists and physicians should know how to differentiate CPV from other bullous autoimmune diseases more common in childhood.

Citing Articles

Diagnosis, treatment, and long-term outcomes of pediatric pemphigus: a retrospective study at tertiary medical centers.

Renert-Yuval Y, Baum S, Greenberger S, Cohen-Barak E, Oren-Shabtai M, Ben-Amitai D Int J Dermatol. 2024; 63(12):1755-1760.

PMID: 38819034 PMC: 11589010. DOI: 10.1111/ijd.17251.


Juvenile pemphigus vulgaris: Literature review and a rare case report.

Sriram S, Hasan S, Mansoori S, Saeed S, Banerjee A, Ramalingam K Clin Case Rep. 2024; 12(5):e8954.

PMID: 38756617 PMC: 11096281. DOI: 10.1002/ccr3.8954.


Severe Pemphigus Vulgaris Resistant to Conventional Therapies and with Hypersensitivity to Rituximab in a 12-Year-Old Child.

de Felici Del Giudice M, Calanca C, Sassetti C, Caffarelli C, Feliciani C, Esposito S Children (Basel). 2023; 10(6).

PMID: 37371152 PMC: 10297657. DOI: 10.3390/children10060920.


Childhood Pemphigus Vulgaris during COVID-19 Outbreak Successfully Treated with Prednisone and Azathioprine: A Case Report and Literature Review.

Vezzoli P, Parietti M, Carugno A, Di Mercurio M, Benaglia C, Zussino M J Clin Med. 2022; 11(22).

PMID: 36431335 PMC: 9696635. DOI: 10.3390/jcm11226858.


Simultaneous Oral and Umbilical Locations as a First Sign of Pemphigus Vulgaris.

Moussaoui E, Oueslati Y, Oualha L, Denguezli M, Sriha B, Douki N Case Rep Dent. 2021; 2021:7792360.

PMID: 34733562 PMC: 8560286. DOI: 10.1155/2021/7792360.

References
1.
Suliman N, Astrom A, Ali R, Salman H, Johannessen A . Clinical and histological characterization of oral pemphigus lesions in patients with skin diseases: a cross sectional study from Sudan. BMC Oral Health. 2013; 13:66. PMC: 3871015. DOI: 10.1186/1472-6831-13-66. View

2.
Fuertes I, Guilabert A, Mascaro Jr J, Iranzo P . Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature. Dermatology. 2010; 221(1):13-6. DOI: 10.1159/000287254. View

3.
Kincaid L, Weinstein M . Rituximab Therapy for Childhood Pemphigus Vulgaris. Pediatr Dermatol. 2016; 33(2):e61-4. DOI: 10.1111/pde.12744. View

4.
Casuriaga Lamboglia A, Minut Gubitosi A, Guebenlian Bakerdjian C, Giachetto Larraz G . [Pemphigus vulgaris in pediatrics: A case report]. Rev Chil Pediatr. 2018; 89(5):650-654. DOI: 10.4067/S0370-41062018005000708. View

5.
Gurcan H, Mabrouk D, Ahmed A . Management of pemphigus in pediatric patients. Minerva Pediatr. 2011; 63(4):279-91. View